Target intelligence / Profile preview

Fe2+-heme in digestive vacuole

Molecular classification
Other
01

Overview

Fe2+-heme in the digestive vacuole refers to the ferrous (Fe2+) form of the heme molecule liberated during hemoglobin digestion by malaria parasites such as *Plasmodium falciparum*. The digestive vacuole acts as a lysosome-like organelle where proteases break down hemoglobin; the resulting free heme (primarily in the Fe2+ oxidation state) is highly toxic to the parasite. The parasite converts it to an inert crystalline form called hemozoin; inhibition of this biocrystallization is the basis for several key antimalarial drug classes, including chloroquine. Fe2+-heme itself is not a receptor, enzyme, or protein but a molecular species and a critical intermediary in *Plasmodium* biology—its accumulation or improper detoxification is a validated target for antimalarial chemotherapy. This target is atypical (not a conventional protein drug target), and the entry may be considered non-standard or “incorrect” by strict pharmacological target nomenclature[1].

Other names
heme iron(II) in digestive vacuoleFe(II)-heme in *Plasmodium* digestive vacuoleheme iron in food vacuole
02

Mechanism of action

Inhibition of heme biocrystallization (blockade of hemozoin formation) Accumulation of toxic Fe2+-heme in the vacuole, leading to parasite death

03

Biological functions

Hemoglobin degradationHeme detoxificationNutrient acquisition
04

Disease associations

Infection (specifically malaria)Other (critical for parasite survival in host cells)
05

Safety considerations

Rapid emergence of drug resistance (especially to chloroquine)Off-target reactive oxygen species (ROS) from iron mismanagement
06

Interacting drugs

Chloroquine

2 more in the full profile.

07

Biomarkers

Hemozoin (malaria pigment, reflects ongoing hemoglobin digestion and drug sensitivity)Chloroquine resistance transporter (PfCRT) status (for drug efficacy)

Beyond the preview

Go deeper on Fe2+-heme in digestive vacuole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fe2+-heme in digestive vacuole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call